RSSCategory: Current Affairs

XIFIN Partners with PWNHealth to Offer Lab Services for Direct-to-Consumer Testing, Employer-Based Screening and Telegenetic Counseling

| June 7, 2017 | 0 Comments

XIFIN Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, today announced a partnership agreement with PWNHealth LLC, a virtual care company offering safe and easy access to diagnostic testing services and professional guidance. The agreement allows XIFIN to market PWN’s services as a complementary offering to XIFIN’s suite of connected health solutions – including […]

Continue Reading

FDA Approval of Immunotherapy For MSI-High or Mismatch Repair Deficient Tumors

| June 5, 2017 | 0 Comments

Last month the FDA approved pembrolizumab (KEYTRUDA) for adult and pediatric patients with with metastatic or unresectable, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors that have progressed following prior treatment. KEYTRUDA has also been approved fro MSI-H or dMMR colorectal cancers that have progressed following treatment with conventional chemotherapies. The immunooncology/immunotherapy story is fascinating. […]

Continue Reading

Leica Biosystems Aperio Digital Pathology now Nationwide Standard of Care in Kuwait*

| May 23, 2017 | 0 Comments

VISTA, CALIFORNIA – Leica Biosystems announced today that it has struck a key partnership with the Kuwait Ministry of Health, through its distributor, Technical Services Supplies Trading & Contracting Company, W.L.L. The Pathology Council of Kuwait will now adopt Leica Biosystems digital pathology as its standard of care. This initiative will create a nationwide pathology network, […]

Continue Reading

“Digital Pathology Stands to Reduce Cancer Misdiagnoses”

| May 21, 2017 | 0 Comments

With the ink dry about a month on the recent FDA approval of Philips Intellisite Pathology Solution (PIPS) for primary diagnosis, I came across this headline and others like it last week. Well known, respected pathologists and pathology informaticians at well-known cancer centers provided quotes for the articles. When you contribute to an article, you […]

Continue Reading

What does FDA Approval Mean for the Digital Pathology Market? Part 1

| May 15, 2017 | 0 Comments

Much is being said, written and discussed about the recent FDA clearance for Philips digital pathology solution for primary surgical pathology diagnosis. Of course, this means an advantage for Philips right now in the market as the only FDA approved whole slide imaging system for primary diagnosis. For groups and hospitals that appreciate the two main […]

Continue Reading

ASI’s HiPath™ For Computer-Assisted PD-L1 Interpretation

| May 12, 2017 | 0 Comments

HiPath™ Supports Pathologists with Advanced Image Analysis of PD-L1 Assays CARLSBAD, CA, May 11, 2017 — Applied Spectral Imaging (ASI), a global leader of computer-assisted microscopy, introduces HiPath imaging and analysis of PD-L1 assays. PD-L1 is seen as the current breakthrough therapeutic target in immuno-oncology. Following recent clinical advances, PD-L1 expression has become a key factor in […]

Continue Reading

Leica Biosystems Applauds FDA Primary Diagnosis Clearance as a Step Forward in Clinical Acceptance of Digital Pathology

| May 11, 2017 | 0 Comments

VISTA, CA – May 11, 2017 – The digital pathology industry just took another step forward, with the FDA clearance of a whole slide imaging (WSI) system (Philips IntelliSite™ Pathology Solution) for review of digital surgical pathology slides. Leica Biosystems congratulates both the FDA and the Digital Pathology Association (DPA) on this positive outcome from […]

Continue Reading

Leslie’s Story & Efforts for Metastatic Breast Cancer Patients

Last October I wrote about “Riding a Bike Versus the Hard Part” after riding in a 3-day event where I met many patients, their friends and family and the challenges they face every day. Leading up to both of these rides on the East and West coast last Fall I met Leslie through social media […]

Continue Reading

Guest Post: AI vs MD – What it Means for Pathology

AI vs MD: What it means for Pathology By David West, CEO, Proscia Will computers replace doctors? It’s the question on everyone’s mind when reading Siddhartha Mukherjee’s article in the New Yorker “AI vs MD”, which pits human doctors against computers. It’s a beautifully composed summary on the role of software algorithms in healthcare, examining […]

Continue Reading

Visiopharm Engages in Major Initiative for Deep Learning in Tissue Based Pathology

Hørsholm, Denmark, May 3rd – Visiopharm A/S announces the first result of their multifaceted strategy to apply Deep Learning technologies to its leading image analysis solution for cancer research and diagnostics. Visiopharm considers Deep Learning an important technological breakthrough for tissue pathology that offers the potential to make a real difference in the assessment of […]

Continue Reading

HALO® Deep Learning Technology Awarded for Automated Breast Cancer Metastasis Staging

Indica Labs proudly announces its breakthrough HALO® Deep Learning technology excelled in the CameLyon17 diagnostic image analysis competition.  The international challenge engaged commercial and academic teams worldwide to develop deep-learning algorithms to analyze 500 whole-slide H&E lymph node images and calculate TNM staging of 100 breast cancer patients. The HALO Deep Learning solution was the […]

Continue Reading

Proscia Takes on Subjectivity in Pathology Through AI Innovation

| April 27, 2017 | 0 Comments

Proscia continues to demonstrate the potential for its technology demonstrating agreement between its algorithms and pathologist reads in detection and classification of breast cancer. Proscia Inc., a data and analytics solutions provider for digital pathology, today announced their digital pathology technology has the potential to eliminate subjectivity in the detection and classification of breast cancer. Using […]

Continue Reading

TRIBVN Healthcare and its Partner Hamamatsu are Supporting the Pathology Department at the University Hospital Centre of Montreal in its Digital Transition 

| April 24, 2017 | 0 Comments

TRIBVN Healthcare, Hamamatsu Photonics and the University Hospital Centre of Montreal have joined forces in a partnership for the creation of a centre of excellence in digital pathology In 2015, the University Hospital Centre of Montreal (CHUM) launched a public consultation for the initiation of the transition of its pathology department to digital technology. The […]

Continue Reading

Dr. Michael Becich to Give Keynote Address “Towards A Digital Pathology Commons” at Pathology Visions 2017

| April 21, 2017 | 0 Comments

 KEYNOTE PRESENTER ANNOUNCED Michael J. Becich, MD, PhD Chairman and Distinguished University Professor University of Pittsburgh School of Medicine The DPA is pleased to announce that Dr. Michael Becich will give the Keynote Address entitled Towards A Digital Pathology Commons at Pathology Visions 2017.  Dr. Mike Becich is an experimental surgical pathologist who is focused on translational informatics. […]

Continue Reading